Federal Contractor Profile
Ridgeback Biotherapeutics LP
$34M obligated·2 awards·1 agencies·1 NAICS
Federal Contracts
Showing contracts 1–6 of 6 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Apr 19, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00009 | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $1.5M |
| Oct 29, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00009 | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $3.4M |
| Aug 14, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00009 | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $1.4M |
| Feb 4, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00009 | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $3.0M |
| Mar 19, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120C00009 | 541713 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. | $11M |
| Sep 5, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50119C00059 | 541713 | CMC EFFORTS FOR MAB114 DEVELOPMENT FOR THE TREATMENT OF EBOLA. | $14M |
Get Alerted Before Ridgeback Biotherapeutics LP's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free